CIK 0001401914
- Non-accelerated filer
- Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 204139823
- Phone
- +1 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-05 | Senderowicz Adrian SVP, Chief Medical Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2017-01-05 | Senderowicz Adrian SVP, Chief Medical Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2016-08-22 | Senderowicz Adrian SVP, Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2016-01-05 | Senderowicz Adrian SVP, Chief Medical Officer | Grant or award · Incentive Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2015-12-01 | Senderowicz Adrian SVP, Chief Medical Officer | Grant or award · Incentive Stock Option (right to buy) | +158,000 | 158,000 | ||
| 2015-09-04 | Senderowicz Adrian SVP, Chief Medical Officer | Grant or award · Incentive Stock Option (right to buy) | +135,000 | 135,000 |
Page 1 of 1 · 6 trades